PMA and PMMA both come up in the same conversations; they overlap on Serotonin and Dopamine. PMA: PMA (para-methoxyamphetamine) is a ring-methoxylated amphetamine that acts as a potent serotonin releaser with additional monoamine oxidase inhibitory activity, a combination that drives a dangerous rise in synaptic serotonin. PMMA: PMMA (para-methoxymethamphetamine) is the N-methylated homolog of PMA and shares its hazardous profile as a serotonin releaser with monoamine oxidase inhibitory activity.
PMA (para-methoxyamphetamine) is a ring-methoxylated amphetamine that acts as a potent serotonin releaser with additional monoamine oxidase inhibitory activity, a combination that drives a dangerous rise in synaptic serotonin. It has repeatedly been sold deceptively as MDMA or ecstasy, earning the street name "death." Its slow onset relative to MDMA has led users to redose in the belief that nothing is happening, precipitating severe serotonergic toxicity; clinical series document hyperthermia, seizures, arrhythmias, and characteristic hypoglycemia and hyperkalemia, and forensic reviews link it to numerous fatalities dating back to a cluster of deaths in Ontario in 1973. It is markedly more toxic than MDMA and is regarded as one of the more hazardous substances ever passed off as ecstasy.
PMMA (para-methoxymethamphetamine) is the N-methylated homolog of PMA and shares its hazardous profile as a serotonin releaser with monoamine oxidase inhibitory activity. Like PMA it comes on slowly and carries a high risk of fatal hyperthermia, and the two are frequently found together in tablets misrepresented as MDMA. Preclinical work shows lasting serotonergic effects on brain serotonin markers, while human studies of fatal cases have detailed its metabolism and a pronounced dependence on CYP2D6 genotype, which may contribute to variable and unpredictable toxicity between individuals. PMMA has been implicated in epidemic clusters of ecstasy-related deaths, including a notable wave in Norway, and is considered among the substances most strongly linked to such fatalities.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
Releaser
Releaser
Inhibitor
Inhibitor
Releaser
Releaser
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.